Yuan-Chin Tsai

702 citations
22 papers · 575 indexed · h-index 15
Topics
Cancer therapeutics and mechanisms (8 papers)Bioactive Compounds and Antitumor Agents (5 papers)Prostate Cancer Treatment and Research (4 papers)

In The Last Decade

Yuan-Chin Tsai

22 papers receiving 571 citations

Peers

Yuan-Chin Tsai
Comparison fields: 5 of 70
  • Molecular Biology 367
  • Oncology 122
  • Cancer Research 97
  • Pulmonary and Respiratory Medicine 90
  • Geriatrics and Gerontology 77
Replace Xiaodan Sun with:
Xiaodan Sun China
Lee Farrand South Korea
Olivia Aranha United States
Valentina Della Pietra Italy
Nianping Chen China
Pei Yen Yeh Taiwan
Dong Hou China
Enrique García‐Villa Mexico
Parijat Senapati India
J Duraj Slovakia
Yuan-Chin Tsai relative to Xiaodan Sun China Xiaodan Sun's profile →
Citations per field
00.5×4.8×
Xiaodan Sun · 1×
Citations per year

Countries citing papers authored by Yuan-Chin Tsai

Since Specialization
Citations

This map shows the geographic impact of Yuan-Chin Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan-Chin Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan-Chin Tsai more than expected).

Fields of papers citing papers by Yuan-Chin Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan-Chin Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan-Chin Tsai. The network helps show where Yuan-Chin Tsai may publish in the future.

Co-authorship network of co-authors of Yuan-Chin Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan-Chin Tsai. A scholar is included among the top collaborators of Yuan-Chin Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan-Chin Tsai. Yuan-Chin Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 6
3 12
4 47
5 15
6 22
7 26
8 51
9 25
10 97
11 45
12 20
13 14
14 14
15 10
16 18
17 10
18 7
19 19
20 67

About Yuan-Chin Tsai

Yuan-Chin Tsai is a scholar working on Toxicology, Cancer Research and Molecular Biology, having authored 22 papers that have together received 575 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Geriatrics and Gerontology (77 citations), Toxicology (40 citations) and Cancer Research (97 citations). Yuan-Chin Tsai has collaborated with scholars based in United States, Taiwan and Lebanon. Frequent co-authors include Ileana M. Cristea, Todd M. Greco, Leroy F. Liu, Angela A. Liu, Wei‐Yu Chen, Yen‐Nien Liu, Edmond J. LaVoie, Haiyan Qi, Mavurapu Satyanarayana and Wei Feng. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026